Tag archive for ‘FDA’
Bristol Myers Squibb, bluebird bio bag Abecma FDA approval for multiple myeloma in adults
By businessnewstoday On Sunday, March 28th, 2021
0 Comments

BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults

(adsbygoogle = window.adsbygoogle || []).push({}); Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food and Drug Administration (FDA) for Abecma More...

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization
By businessnewstoday On Sunday, February 28th, 2021
0 Comments

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine developed by its subsidiary Janssen More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, February 28th, 2021
0 Comments

FDA authorizes emergency use of Janssen COVID-19 Vaccine

The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine – Ad26.COV2.S manufactured by Johnson & Johnson subsidiary Janssen Biotech. It More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Monday, February 15th, 2021
0 Comments

G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression

G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela FDA approval is for its use in cutting More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Monday, February 15th, 2021
0 Comments

G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression

G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela FDA approval is for its use in cutting More...

By pharmanewsdaily On Tuesday, January 26th, 2021
0 Comments

US FDA approves Opdivo, Cabometyx combo for advanced renal cell carcinoma

The US Food and Drug Administration (FDA) has approved the combination of Bristol Myers Squibb’ Opdivo (nivolumab) and Exelixis’ Cabometyx (cabozantinib) as a first line therapy for advanced renal cell carcinoma More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Tuesday, January 26th, 2021
0 Comments

US FDA approves Opdivo, Cabometyx combo for advanced renal cell carcinoma

The US Food and Drug Administration (FDA) has approved the combination of Bristol Myers Squibb’ Opdivo (nivolumab) and Exelixis’ Cabometyx (cabozantinib) as a first line therapy for advanced renal cell carcinoma More...

By pharmanewsdaily On Saturday, January 16th, 2021
0 Comments

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug Administration (FDA) for DARZALEX FASPRO (daratumumab More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Saturday, January 16th, 2021
0 Comments

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug Administration (FDA) for DARZALEX FASPRO (daratumumab More...

By pharmanewsdaily On Saturday, December 19th, 2020
0 Comments

AstraZeneca gets FDA approval for Tagrisso for type of NSCLC

AstraZeneca has secured extended approval from the US Food and Drug Administration for using Tagrisso (osimertinib) as an adjuvant treatment of non-small cell lung cancer (NSCLC) in patients whose tumors have a More...